Scott Wilkinson

17PUBLICATIONS
137CO-AUTHORS
Molecular targetsInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Deep learningPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Oct 08, 2025
Elucidating molecularly stratified single agent, and combination, therapeutic strategies targeting MCL1 for lethal prostate cancer.

Juan M Jiménez-Vacas, Daniel Westaby, Ines Figueiredo

|Dec 09, 2024
Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate Cancer.

Lisa N Chesner, Fanny Polesso, Julie N Graff

|Feb 19, 2024
Localized high-risk prostate cancer harbors an androgen receptor low subpopulation susceptible to HER2 inhibition.

Scott Wilkinson, Anson T Ku, Rosina T Lis

|Oct 04, 2023
Prediction of cancer treatment response from histopathology images through imputed transcriptomics.

Danh-Tai Hoang, Gal Dinstag, Leandro C Hermida

Pageof 3